A carregar...
(188)Re-HEDP therapy in the therapy of painful bone metastases
For bone-targeted radionuclide therapy (BTRT), different commercial radiopharmaceuticals are available such as strontium-89, (186)Rhenium-hydroxyethylidene diphosphonate ((186)Re-HEDP), Samarium-153-ethylenediamine tetramethylene phosphonic acid, and radium-223. Unfortunately, the commercial availab...
Na minha lista:
| Publicado no: | World J Nucl Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6034542/ https://ncbi.nlm.nih.gov/pubmed/30034275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/wjnm.WJNM_85_17 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|